Eye movement affects glaucomatous vision
Certain eye movement patterns seem to be associated with better face recognition performance in patients with central glaucomatous visual field loss.
CLAO ERF, SSF to sponsor award for dry eye study
A scientific research grant to cover studies related to dry eye and ocular surface disease will be awarded by CLAO ERF in association with the SSF.
Intracorneal inlay now available in Canada
AcuFocus Inc. has received approval from Health Canada to market and sell the Kamra inlay, an innovative corneal inlay to treat presbyopia, within Canada.
Besifloxacin ophthalmic suspension gains additional indications
The FDA has granted additional labeling indications for besifloxacin ophthalmic suspension 0.6% (Besivance, Bausch + Lomb).
Early ocular surface-related complications common after CXL
A study provides new insight on the risk of early ocular surface-related complications among patients undergoing CXL for keratoconus.
Aberrometer receives CE Mark
The iDesign aberrometer (Abbott) provides an advanced, high-definition measurement device for wavefront-guided LASIK procedures.
Alcon adds to AcrySof family of presbyopia-correcting IOLs
The AcrySof IQ ReSTOR +2.5-D IOL offers sharp distance vision with an additional range of vision beyond a standard monofocal lens.
Editor's Blog: Can ophthalmology find technological 'global harmony'?
In today's blog from ESCRS, Mark Dlugoss, Ophthalmology Times editor-in-chief, discusses ophthalmic technologies and FDA-related availability issues.
STAAR Surgical announces management additions, promotions
The company promotes two and adds another employee as it names three vice presidents.
UK accepts additional data for DME implant
Pseudophakic patients may benefit from a fluocinolone acetonide intravitreal implant (Iluvien, Alimera Sciences), the company tells a United Kingdom committee.
Cellular-scale retinal camera receives CE mark
A cellular-level adaptive optics retinal camera (rtx1, Imagine Eyes) has received CE mark approval in the European Union.
Sealant being studied for clear corneal wound closure
A new sealant (ReSure, Ocular Therapeutix) will be studied for clear corneal incision closure after cataract extraction or IOL placement.
New drug delivery system aims to increase tissue penetration
Improved efficacy and dosing convenience are the aims of a new drug delivery system incorporating a cationic polymer and formulated with ketorolac.
New data confirm efficacy, safety of ranibizumab
New data presented at the European Society of Retina Specialists meeting suggest that ranibizumab is effective in patients with AMD, DME, and RVO.
Encourage patients with bilateral vision loss to be more active
Newly published research gives ophthalmologists a reason to encourage their adult patients with visual field loss in both eyes to be more physically active.
Editor's Blog: Ophthalmologists from around the world come to learn
Mark Dlugoss, Ophthalmology Times editor-in-chief, is blogging daily from ESCRS. Today he discusses the attendance of Latin American physicians at ESCRS.
Editor's Blog: The year of intraocular lenses (IOLs)
Ophthalmology Times editor-in-chief, Mark Dlugoss, is blogging daily from ESCRS. Today he discusses various releases of intraocular lenses (IOLs).
Editor's Blog: ESCRS grown to become a unique ophthalmic meeting
Ophthalmology Times Editor-in-Chief, Mark Dlugoss, blogs daily from the 2012 congress of the European Society of Cataract and Refractive Surgeons (ESCRS).
Cause of cone death discovered in retinitis pigmentosa
Researchers have identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigments (RP).
Wilmer Eye Institute awarded AHAF grants for glaucoma and AMD
Glaucoma and age-related macular degeneration (AMD) research grants have been awarded to Wilmer Eye Institute by the American Health Assistance Foundation.
Welch Allyn facility earns LEED environmental certification
The Welch Allyn facility in Beaverton, OR, earned Leadership in Energy and Environmental Design (LEED) certification from the U.S. Green Building Council.
Moore named Iridex interim president, CEO
William M. Moore has been named interim president and chief executive officer of Iridex Corp. Moore succeeds Dominik Beck.
STAAR Surgical consolidates lens operations in Monrovia, CA
Implantable contact lens and preloaded IOL manufacturing will move to California in a consolidation project now under way at STAAR Surgical.
Glaucoma may be linked to depression
Glaucoma may be a significant predictor of depression, according to research published in the American Journal of Ophthalmology.
FDA clears laser for cataract surgery incisions
The FDA approved OptiMedica's Catalys Precision for creating single-plane and multi-plane arc incisions in the cornea during cataract surgery.
Trifocal diffractive intraocular lens reduces spectacle dependency
A trifocal diffractive intraocular lens (FineVision IOL, PhysIOL) reduces spectacle dependence after cataract surgery and provides patient satisfaction.
Phase II study for travoprost punctum plugs
Ocular Therapeutix Inc. is initiating a phase II clinical trial of OTX-TP2, a 2-month travoprost punctum plug for treating ocular hypertension and glaucoma.
Allergan, Molecular Partners enter DARPin agreements
Allergan Inc. and Molecular Partners AG have entered into two agreements to discover, develop, and commercialize proprietary therapeutic designed ankyrin repeat protein (DARPin) products for the treatment of opthalmic diseases.
Gevokizumab receives orphan drug designation
Gevokizumab, an IL-1 beta-modulating antibody from XOMA Corp., has received FDA orphan drug designation for the treatment of several types of non-infectious uveitis.
Laser surgery education gets $1 million boost
Ophthalmologists will have a new way to learn about advances in laser surgery next year, thanks to a $1 million donation made to the American Academy of Ophthalmology.
